NEPH — Nephros Inc

Nephros Inc (NEPH) is a medical instruments & supplies company listed on NASDAQ. It is led by Robert Banks, based in 380 Lackawanna Place, South Orange, NJ, United States, 07079, with about 31 employees. Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Latest reported NEPH revenue for 2025-09-30 was $4.8M. Net income was $337.0K. Revenue was up 7.8% from 2025-06-30 to 2025-09-30. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.

Use this NEPH page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NEPH quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NEPH SEC filings page. Lician reads the product cache first so this HTML stays unique to Nephros Inc even when a live quote feed is slow.